Kiker Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-137
Closed -$15.2K 388
2025
Q2
$15.2K Sell
137
-30
-18% -$3.19K 0.01% 316
2025
Q1
$18.8K Buy
+167
New +$17.2K 0.01% 306

Other funds holding GILD

Kiker Wealth Management's GILD Position: Q3 2025 in Review

Kiker Wealth Management sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 137 shares — an estimated $15.2K sold.

Kiker Wealth Management first reported a position in GILD in Q1 2025 and held it in 2 quarters. The position peaked at $18.8K in Q1 2025. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Kiker Wealth Management reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
  • Kiker Wealth Management sold 137 Gilead Sciences shares in Q3 2025, an estimated $15.2K.
  • Kiker Wealth Management first reported a position in Gilead Sciences in Q1 2025 and held it in 2 quarters.
  • Kiker Wealth Management's Gilead Sciences position peaked at $18.8K in Q1 2025.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Kiker Wealth Management's 13F filing for Q3 2025, filed 27 Oct 2025.